After leaving Google, Jakob Uszkoreit started Inceptive to apply AI to drug development

Before co-founding a biotech startup, an individual had an idea that led to the development of generative artificial intelligence. As a researcher, the individual suggested using a new way to interpret data called self-attention, which eventually gave rise to the transformer neural network architecture. This technology has been used in various applications by different companies. The individual mentioned that larger companies like Google may not have been as daring in applying this technology to different products compared to smaller companies like OpenAI. The individual left Google to co-found a biological software company focused on using AI for drug development. They emphasize the potential of their approach to create medicines that better align with living systems.